Paper37166702
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.
Malar DS and 5 others. CNS Drugs, 2023. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. Papers, record 37166702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37166702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, sigma | Major topic |
| Amyotrophic Lateral Sclerosis | Major topic |
| Huntington Disease | Major topic |
| Neurodevelopmental Disorders | Major topic |
| Humans | |
| Neurons |
Source PubMed
References417
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10066203 | Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. | BMJ | 1999 | https://conductscience.org/library/papers/10066203 | PubMed |
| 2 | 19370737 | Randomized controlled trial of memantine in dementia associated with Parkinson's disease. | Mov Disord | 2009 | https://conductscience.org/library/papers/19370737 | PubMed |
| 3 | 22935988 | Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. | Neurotherapeutics | 2012 | https://conductscience.org/library/papers/22935988 | PubMed |
| 4 | 20071528 | Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. | J Neurosci | 2010 | https://conductscience.org/library/papers/20071528 | PubMed |
| 5 | 26595642 | Lewy body dementias. | Lancet | 2015 | https://conductscience.org/library/papers/26595642 | PubMed |
| 6 | 27926996 | Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease. | J Neurochem | 2017 | https://conductscience.org/library/papers/27926996 | PubMed |
| 7 | 29966437 | Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations. | Future Med Chem | 2018 | https://conductscience.org/library/papers/29966437 | PubMed |
| 8 | 32318621 | A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study. | Alzheimers Dement (N Y) | 2020 | https://conductscience.org/library/papers/32318621 | PubMed |
| 9 | 30832324 | Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo. | Cells | 2019 | https://conductscience.org/library/papers/30832324 | PubMed |
| 10 | 15377746 | Fluvoxamine treatment of major depression associated with multiple sclerosis. | J Neuropsychiatry Clin Neurosci | 2004 | https://conductscience.org/library/papers/15377746 | PubMed |
| 11 | 6363736 | Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam. | JAMA | 1984 | https://conductscience.org/library/papers/6363736 | PubMed |
| 12 | 25521311 | High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/25521311 | PubMed |
| 13 | 34260979 | Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis. | Respir Med | 2021 | https://conductscience.org/library/papers/34260979 | PubMed |
| 14 | 23922215 | Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy. | Med Res Rev | 2014 | https://conductscience.org/library/papers/23922215 | PubMed |
| 15 | 32049741 | What are the epileptic encephalopathies? | Curr Opin Neurol | 2020 | https://conductscience.org/library/papers/32049741 | PubMed |
| 16 | 21212100 | Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21212100 | PubMed |
| 17 | 32284590 | Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. | Nat Med | 2020 | https://conductscience.org/library/papers/32284590 | PubMed |
| 18 | 34445144 | An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445144 | PubMed |
| 19 | 23450660 | A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease. | Mov Disord | 2013 | https://conductscience.org/library/papers/23450660 | PubMed |
| 20 | 1717296 | Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. | Eur J Pharmacol | 1991 | https://conductscience.org/library/papers/1717296 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985291 | Integrating multi-receptor and neuron-glia mechanisms of ketamine's antidepressant action: a convergence framework for understanding efficacy. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42985291 | PubMed |
| 42819592 | Blarcamesine improves EEG biomarkers of cortical dysfunction in a mouse model of fragile X syndrome. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42819592 | PubMed |
| 42769292 | A neuroprotective target in the shadows: a scoping review of pharmacological gaps in σ1R agonists for glutamate-induced neurotoxicity. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42769292 | PubMed |
| 42738830 | Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER-Mitochondria Tethering Proteins via Inhibition of GSK3β. | Cells | 2026 | https://conductscience.org/library/papers/42738830 | PubMed |
| 42560467 | Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review. | CNS Drugs | 2026 | https://conductscience.org/library/papers/42560467 | PubMed |
| 42313219 | Alzheimer's Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42313219 | PubMed |
| 42074241 | Cognitive Stimulation and Activity-Dependent Myelination: Oligodendroglial Mechanisms Linking Neural Activity and Brain Plasticity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074241 | PubMed |
| 42074133 | Pridopidine Protects ALS Patient-Derived Neural Progenitor Cells via Sigma-1 Receptor Activation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074133 | PubMed |
| 42039150 | Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer's disease therapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42039150 | PubMed |
| 42022042 | SA4503 plays a protective role in post-resuscitation injury by reducing apoptosis caused by mitochondrial dysfunction and endoplasmic reticulum stress through the activation of sigma-1 receptor. | Cytojournal | 2026 | https://conductscience.org/library/papers/42022042 | PubMed |
| 41859358 | From metabolism to mood regulation: astrocytes as a driver of depression. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41859358 | PubMed |
| 41657419 | Current and emerging therapeutic strategies for amyotrophic lateral sclerosis: from pharmacological approaches to gene and stem cell therapies. | Front Neurol | 2026 | https://conductscience.org/library/papers/41657419 | PubMed |
| 41518900 | Dual sigma receptor 1 and 2 modulator improves memory behavior in mouse model of age-related cognitive decline. | J Pharmacol Exp Ther | 2026 | https://conductscience.org/library/papers/41518900 | PubMed |
| 41488323 | Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer's disease. | Front Neurosci | 2025 | https://conductscience.org/library/papers/41488323 | PubMed |
| 41471389 | Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471389 | PubMed |
| 41269403 | Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's Disease. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41269403 | PubMed |
| 41020314 | Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management. | Med Res Rev | 2026 | https://conductscience.org/library/papers/41020314 | PubMed |
| 40965607 | Sigma-1 Receptor Ligands for CNS Cancer Treatment. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40965607 | PubMed |
| 40957903 | Sustained antidepressant actions of ketamine involve TAMM41-mediated transfer of astrocytic sigma-1 receptor to neuron. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/40957903 | PubMed |
| 40956957 | Targeting the Milieu in Neurodegenerative Disease: Time for "Imprecision Medicine"? | Aging Dis | 2025 | https://conductscience.org/library/papers/40956957 | PubMed |
Genes80
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37166702
GET https://conductscience.org/api/papers/v1/37166702/references?page=2